Current approaches and future role of high content imaging in safety sciences and drug discovery
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
High content imaging combines automated microscopy with image analysis approaches to simultaneously quantify multiple phenotypic and/or functional parameters in biological systems. The technology has become an important tool in the fields of safety sciences and drug discovery, because it can be used for mode-of-action identification, determination of hazard potency and the discovery of toxicity targets and biomarkers. In contrast to conventional biochemical endpoints, high content imaging provides insight into the spatial distribution and dynamics of responses in biological systems. This allows the identification of signaling pathways underlying cell defense, adaptation, toxicity and death. Therefore, high content imaging is considered a promising technology to address the challenges for the "Toxicity testing in the 21st century" approach. Currently, high content imaging technologies are frequently applied in academia for mechanistic toxicity studies and in pharmaceutical industry for the ranking and selection of lead drug compounds or to identify/confirm mechanisms underlying effects observed in vivo. A recent workshop gathered scientists working on high content imaging in academia, pharmaceutical industry and regulatory bodies with the objective to compile the state-of-the-art of the technology in the different institutions. Together they defined technical and methodological gaps, proposed quality control measures and performance standards, highlighted cell sources and new readouts and discussed future requirements for regulatory implementation. This review summarizes the discussion, proposed solutions and recommendations of the specialists contributing to the workshop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
Integrating high-content screening and ligand-target prediction to identify mechanism of action
Young, D. W., Bender, A., Hoyt, J., McWhinnie, E., Chirn, G.-W., Tao, C. Y., Tallarico, J. A., Labow, M., Jenkins, J. L., Mitchison, T. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.53 · Cited by 345
Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
Kleinstreuer, N. C., Yang, J., Berg, E. L., Knudsen, T. B., Richard, A. M., Martin, M. T., Reif, D. M., Judson, R. S., Polokoff, M., Dix, D. J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2914 · Cited by 211 · cited 1×
“Such efforts have already been initiated by ToxCast (Kleinstreuer et al., 2014), the Tox21 programs (Zang et al.”
BackgroundBaker, M. (2011) · Nature · doi:10.1038/471661a · Cited by 188 · cited 1×
“An even more complex acquisition technology includes the "organ on a chip approach," which uses a 3D microftuidic cell culture chip that can both measure and simulate the activities, mechanics and physiological responses of entire organs or organ systems (Huh et al., 2011; Baker, 2011).”
BackgroundKramer, N. I., Krismartina, M., Rico-Rico, Á., Blaauboer, B. J., & Hermens, J. L. M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200479k · Cited by 156 · cited 2×
“When a certain concentration (nominal) of a compound is added to an in vitro system, a part of the compound will be bound, e.g., to the proteins in the cell culture media (e.g., serum) and the plastic of the cell culture dish (Kramer et al., 2012 ).”
Background
Cited by
Toxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk
Daneshian, M., Kamp, H., Hengstler, J., Leist, M., & van de Water, B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1698-7 · Cited by 65
(2024) · ALTEX · doi:10.14573/altex.2403281 · Cited by 28
“High-content screening (HCS) methods (van Vliet et al., 2014) have significantly transformed DNT testing by introducing a more nuanced, efficient, and comprehensive approach to evaluating the effects of chemicals on neural development.”
Self-citation
Metadata
- Authors
- van Vliet, E.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2014
- Volume
- 31
- Issue
- 4
- Pages
- 479-493
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2164860630
- Cited by
- 56
- References
- 6
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.